11:19 AM EDT, 06/07/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were heading lower late Friday morning, declining 0.49% to 1,445.71 on the S&P Europe Select ADR Index. Despite the decline, the index is still poised to end the week up about 1.3%.

From continental Europe, the gainers were led by biopharmaceutical company Genfit ( GNFT ) and semiconductor company Sequans Communications ( SQNS ) , which rose 6% and 4.6% respectively. They were followed by medical device maker EDAP (EDAP) and financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) , which were up 1% and 0.6% respectively.

The decliners from continental Europe were led by biopharmaceutical companies DBV Technologies ( DBVT ) and Calliditas Therapeutics ( CALT ) , which fell 10% and 4.6% respectively. They were followed by biopharmaceutical companies Cellectis ( CLLS ) and Grifols ( GRFS ) , which dropped 3.4% and 2.9% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) , which rose 1.5%. It was followed by software firm Endava ( DAVA ) and biopharmaceutical company Mereo BioPharma Group ( MREO ) , which were up 0.9% and 0.7% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm (TCBP) and NuCana ( NCNA ) , which lost 7.8% and 4.7% respectively. They were followed by insurance firm Prudential (PUK) and mining company BHP Group ( BHP ) , which were down 3.4% and 1.6% respectively.